Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib.

Karwaciak I, Sałkowska A, Karaś K, Sobalska-Kwapis M, Walczak-Drzewiecka A, Pułaski Ł, Strapagiel D, Dastych J, Ratajewski M.

Cancers (Basel). 2019 May 14;11(5). pii: E673. doi: 10.3390/cancers11050673.

2.

Digoxin, an Overlooked Agonist of RORγ/RORγT.

Karaś K, Sałkowska A, Sobalska-Kwapis M, Walczak-Drzewiecka A, Strapagiel D, Dastych J, Bachorz RA, Ratajewski M.

Front Pharmacol. 2019 Jan 7;9:1460. doi: 10.3389/fphar.2018.01460. eCollection 2018.

3.

The cardenolides strophanthidin, digoxigenin and dihydroouabain act as activators of the human RORγ/RORγT receptors.

Karaś K, Sałkowska A, Walczak-Drzewiecka A, Ryba K, Dastych J, Bachorz RA, Ratajewski M.

Toxicol Lett. 2018 Oct 1;295:314-324. doi: 10.1016/j.toxlet.2018.07.002. Epub 2018 Jul 5.

PMID:
29981919
4.

Differentiation stage-specific effect of histone deacetylase inhibitors on the expression of RORγT in human lymphocytes.

Sałkowska A, Karaś K, Walczak-Drzewiecka A, Dastych J, Ratajewski M.

J Leukoc Biol. 2017 Dec;102(6):1487-1495. doi: 10.1189/jlb.6A0617-217R. Epub 2017 Sep 26.

PMID:
28951421
5.

Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus.

Borowiec M, Gorzkiewicz M, Grzesik J, Walczak-Drzewiecka A, Salkowska A, Rodakowska E, Steczkiewicz K, Rychlewski L, Dastych J, Ginalski K.

Toxins (Basel). 2016 Nov 10;8(11). pii: E321.

6.

Expression of human gene coding RORγT receptor depends on the Sp2 transcription factor.

Ratajewski M, Walczak-Drzewiecka A, Gorzkiewicz M, Sałkowska A, Dastych J.

J Leukoc Biol. 2016 Nov;100(5):1213-1223. Epub 2016 Jun 2.

PMID:
27256574
7.

Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.

Gendaszewska-Darmach E, Węgłowska E, Walczak-Drzewiecka A, Karaś K.

Oncotarget. 2016 Oct 25;7(43):69358-69370. doi: 10.18632/oncotarget.12541.

8.

Screening of a chemical library reveals novel PXR-activating pharmacologic compounds.

Ratajewski M, Grzelak I, Wiśniewska K, Ryba K, Gorzkiewicz M, Walczak-Drzewiecka A, Hoffmann M, Dastych J.

Toxicol Lett. 2015 Jan 5;232(1):193-202. doi: 10.1016/j.toxlet.2014.10.009. Epub 2014 Oct 16.

PMID:
25455453
9.

Epigenetic regulation of CD34 and HIF1A expression during the differentiation of human mast cells.

Walczak-Drzewiecka A, Salkowska A, Ratajewski M, Dastych J.

Immunogenetics. 2013 Jun;65(6):429-38. doi: 10.1007/s00251-013-0695-8. Epub 2013 Mar 26.

10.

Upstream stimulating factors regulate the expression of RORγT in human lymphocytes.

Ratajewski M, Walczak-Drzewiecka A, Salkowska A, Dastych J.

J Immunol. 2012 Sep 15;189(6):3034-42. doi: 10.4049/jimmunol.1200519. Epub 2012 Aug 13.

11.

Aflatoxins upregulate CYP3A4 mRNA expression in a process that involves the PXR transcription factor.

Ratajewski M, Walczak-Drzewiecka A, Sałkowska A, Dastych J.

Toxicol Lett. 2011 Aug 28;205(2):146-53. doi: 10.1016/j.toxlet.2011.05.1034. Epub 2011 May 27.

PMID:
21641981
12.

Cell cycle-dependent phosphorylation of pRb-like protein in root meristem cells of Vicia faba.

Polit JT, Kaźmierczak A, Walczak-Drzewiecka A.

Protoplasma. 2012 Jan;249(1):131-7. doi: 10.1007/s00709-011-0272-7. Epub 2011 Mar 29.

13.

Identification and analysis of the promoter region of the human DHCR24 gene: involvement of DNA methylation and histone acetylation.

Drzewinska J, Walczak-Drzewiecka A, Ratajewski M.

Mol Biol Rep. 2011 Feb;38(2):1091-101. doi: 10.1007/s11033-010-0206-z. Epub 2010 Jun 22.

PMID:
20568014
14.

DNA methylation-dependent suppression of HIF1A in an immature hematopoietic cell line HMC-1.

Walczak-Drzewiecka A, Ratajewski M, Pułaski Ł, Dastych J.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):1028-32. doi: 10.1016/j.bbrc.2009.12.011. Epub 2009 Dec 6.

PMID:
19995553
15.

HIF-1alpha is up-regulated in activated mast cells by a process that involves calcineurin and NFAT.

Walczak-Drzewiecka A, Ratajewski M, Wagner W, Dastych J.

J Immunol. 2008 Aug 1;181(3):1665-72.

16.

Thymosin beta4 and thymosin beta4-derived peptides induce mast cell exocytosis.

Wyczółkowska J, Walczak-Drzewiecka A, Wagner W, Dastych J.

Peptides. 2007 Apr;28(4):752-9. Epub 2007 Jan 13.

PMID:
17289217
17.

Fluorescent Cell Chip a new in vitro approach for immunotoxicity screening.

Wagner W, Walczak-Drzewiecka A, Slusarczyk A, Biecek P, Rychlewski L, Dastych J.

Toxicol Lett. 2006 Mar 15;162(1):55-70. Epub 2005 Nov 28.

PMID:
16318904
18.

c-Jun N-terminal kinase is involved in mercuric ions-mediated interleukin-4 secretion in mast cells.

Walczak-Drzewiecka A, Wyczółkowska J, Dastych J.

Int Arch Allergy Immunol. 2005 Feb;136(2):181-90. Epub 2005 Feb 8.

PMID:
15711095
19.

Detection of immunotoxicity using T-cell based cytokine reporter cell lines ("Cell Chip").

Ringerike T, Ullerås E, Völker R, Verlaan B, Eikeset A, Trzaska D, Adamczewska V, Olszewski M, Walczak-Drzewiecka A, Arkusz J, van Loveren H, Nilsson G, Lovik M, Dastych J, Vandebriel RJ.

Toxicology. 2005 Jan 15;206(2):257-72.

PMID:
15588918
20.

Development of the "Cell Chip": a new in vitro alternative technique for immunotoxicity testing.

Ullerås E, Trzaska D, Arkusz J, Ringerike T, Adamczewska V, Olszewski M, Wyczółkowska J, Walczak-Drzewiecka A, Al-Nedawi K, Nilsson G, Białek-Wyrzykowska U, Stepnik M, Loveren HV, Vandebriel RJ, Løvik M, Rydzyński K, Dastych J.

Toxicology. 2005 Jan 15;206(2):245-56.

PMID:
15588917

Supplemental Content

Loading ...
Support Center